ConductScience.org, home

Trial · NCT00632411

Evaluating a Telephone-Based Smoking Cessation Program Among People in the Military (The AFIII Study)

NCT00632411, Not applicable, Completed, University of Tennessee; results first posted 2017-05-24

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Evaluating a Telephone-Based Smoking Cessation Program Among People in the Military (The AFIII Study). Trials, record NCT00632411. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00632411

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Evaluating a Telephone-Based Smoking Cessation Program Among People in the Military (The AFIII Study)
NCT number
NCT00632411
Status
Completed
Phases
Not applicable
Enrollment
1,298 participants, actual
Lead sponsor
University of Tennessee
Conditions
Smoking, Smoking Cessation
Interventions
Nicotine Patch, Tobacco Quit Line Program
First posted
2008-03-10
Last updated
2018-03-14
Results first posted
2017-05-24

Source ClinicalTrials.gov

Registered outcomes1

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryContinuous AbstinenceMeasured at Year 1No cigarette smoking since two weeks after the target quit date.

Outcomes1

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYContinuous AbstinenceMeasured at Year 1ParticipantsParticipantsCOUNT_OF_PARTICIPANTS

Results by group2

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Continuous AbstinenceProactive Group173Participants
Continuous AbstinenceReactive Group136Participants

Participant flow6

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDProactive Group649
Overall StudySTARTEDReactive Group649
Overall StudyCOMPLETEDProactive Group489
Overall StudyCOMPLETEDReactive Group473
Overall StudyNOT COMPLETEDProactive Group160
Overall StudyNOT COMPLETEDReactive Group176

Adverse events38

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherHeadacheGeneral disordersProactive Group1464914
otherHeadacheGeneral disordersReactive Group46494
otherSkin RashInjury, poisoning and procedural complicationsProactive Group8864988
otherSkin RashInjury, poisoning and procedural complicationsReactive Group2664926
otherSleep DisturbanceInjury, poisoning and procedural complicationsProactive Group6464964
otherSleep DisturbanceInjury, poisoning and procedural complicationsReactive Group1964919
otherRespiratory illness/ Sinus/ Sore throat/ Cold/Flu/Seasonal allergiesRespiratory, thoracic and mediastinal disordersProactive Group5564955
otherRespiratory illness/ Sinus/ Sore throat/ Cold/Flu/Seasonal allergiesRespiratory, thoracic and mediastinal disordersReactive Group1364913
otherStomach illness/Nausea/DiarrheaInjury, poisoning and procedural complicationsProactive Group3064930
otherStomach illness/Nausea/DiarrheaInjury, poisoning and procedural complicationsReactive Group1464914

Adverse event totals6

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityProactive Group
Total, all-cause mortalityReactive Group
Total, other adverse eventsProactive Group307649
Total, other adverse eventsReactive Group98649
Total, serious adverse eventsProactive Group16649
Total, serious adverse eventsReactive Group6649

Papers6

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
2503780BACKGROUNDPubMed
12002168BACKGROUNDPubMed
15010446BACKGROUNDPubMed
15080246BACKGROUNDPubMed
15163928BACKGROUNDPubMed
26226536DERIVEDPubMed

Grants1

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal years
R18HL053478Efficacy of a Smoking Quit Line in the MilitaryKLESGES, ROBERT CUNIVERSITY OF TENNESSEE HEALTH SCI CTRNATIONAL HEART, LUNG, AND BLOOD INSTITUTE1999 to 2012

Trial comparisons2

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource
Proactive Group vs Reactive Group: Continuous AbstinenceTrial comparisons
Proactive Group vs Reactive Group: serious adverse eventsTrial comparisons

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT00632411

GET https://conductscience.org/api/trials/v1/NCT00632411/events?page=2